← Back
Data updated: Mar 10, 2026
WOCKHARDT USA
Infectious DiseaseOncologyGastroenterology
WOCKHARDT USA is a generic drug manufacturer focused on Infectious Disease, Oncology, Gastroenterology.
2008
Since
4
Drugs
-
Trials
28
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
EXTENDED PHENYTOIN SODIUM 2026-01-02
OCTREOTIDE ACETATE 2025-12-12
GRANISETRON HYDROCHLORIDE 2025-03-24
Labeling
GRANISETRON HYDROCHLORIDE 2025-03-17
OCTREOTIDE ACETATE 2024-10-25
Labeling
OCTREOTIDE ACETATE 2024-09-30
Labeling
OCTREOTIDE ACETATE (PRESERVATIVE FREE) 2024-09-25
Labeling
OCTREOTIDE ACETATE (PRESERVATIVE FREE) 2024-09-25
Labeling
OCTREOTIDE ACETATE 2024-09-25
Labeling
OCTREOTIDE ACETATE 2024-09-25
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 43%
0 drugs Phase 3: 2 Phase 2: 1 Phase 1: 2
Oncology 21%
1 drugs
Gastroenterology 21%
1 drugs
Dermatology 14%
0 drugs Phase 3: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Oncology, Dermatology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Infectious Disease
CASPER PHARMA LLC big-pharma
Infectious Disease, Oncology, Gastroenterology, Dermatology
COSETTE other
Dermatology, Infectious Disease, Oncology
Discontinued (1)
Company Info
- First Approval
- 2008-01-30
- Latest
- 2015-02-25
- Applications
- 7